tiprankstipranks
Advertisement
Advertisement
Tandem Diabetes price target lowered to $17 from $22 at Citi
PremiumThe FlyTandem Diabetes price target lowered to $17 from $22 at Citi
22d ago
Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs
Premium
The Fly
Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs
23d ago
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
Premium
Company Announcements
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
29d ago
Tandem Diabetes initiated with a Hold at Benchmark
PremiumThe FlyTandem Diabetes initiated with a Hold at Benchmark
1M ago
Tandem Diabetes initiated with a Hold at Benchmark
Premium
The Fly
Tandem Diabetes initiated with a Hold at Benchmark
1M ago
Tandem Diabetes price target lowered to $55 from $56 at Barclays
Premium
The Fly
Tandem Diabetes price target lowered to $55 from $56 at Barclays
1M ago
Tandem Diabetes reports Q1 EPS (30c), consensus (44c)
PremiumThe FlyTandem Diabetes reports Q1 EPS (30c), consensus (44c)
1M ago
Tandem Diabetes affirms FY26 revenue view of $1.065B-$1.08B, consensus $1.07B
Premium
The Fly
Tandem Diabetes affirms FY26 revenue view of $1.065B-$1.08B, consensus $1.07B
1M ago
TNDM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TNDM Earnings this Week: How Will it Perform?
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100